ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
|Management Options for Low Back Disorders|
Low back disorders (LBD) are an exceedingly common complaint, with a lifetime prevalence ranging from 54-80%. Chronic low back pain may be seen in 25-60% of patients one year or longer after an initial episode. The economic impact of low back pain is substantial. It is the fifth most common reason for all physician visits in the U.S., and is responsible for direct medical costs that approach $30 billion annually. In addition, low back pain is a major cause of lost productivity; it is estimated that 2% of the U.S. work force is compensated for back pain or injury each year.
This appraisal will evaluate the evidence on the comparative risks, benefits, and cost-effectiveness of multiple management strategies for patients with chronic low back pain (i.e., >4 weeks’ duration) without evidence of systemic disease or significant neurological findings.
A graphic depiction of the patient types reflected in our scope can be found here, as well as a proposed mapping to possible treatment options:
Final Appraisal Documents
Draft Appraisal Documents
Final ERG Meeting
Mid-Cycle Review Documents
Stakeholder organizations invited to participate: